Results 21 to 30 of about 137,942 (365)

Cross-sectional analysis of national testosterone prescribing through prescription drug monitoring programs, 2018-2022. [PDF]

open access: yesPLoS One
Background For two decades preceding the COVID-19 pandemic, testosterone therapy (TT) became more prevalent in the US. Given the forced shift in practice patterns and healthcare accessibility during the pandemic, it was unclear how TT utilization would ...
Selinger S, Thallapureddy A.
europepmc   +2 more sources

Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study. [PDF]

open access: yesMedicine (Baltimore), 2021
Supplemental Digital Content is available in the text Abstract Query of Prescription Drug Monitoring Programs (PDMPs) is recommended before prescribing opioids by the US Centers for Disease Control and Prevention, to inform clinical practice and aid ...
Goodin A   +4 more
europepmc   +2 more sources

Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States. [PDF]

open access: yesEpidemiol Rev, 2020
Prescription drug monitoring programs (PDMPs) are a crucial component of federal and state governments' response to the opioid epidemic. Evidence about the effectiveness of PDMPs in reducing prescription opioid-related adverse outcomes is mixed.
Puac-Polanco V   +5 more
europepmc   +2 more sources

A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy

open access: greenAmerican Journal of Public Health, 2020
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC ...
A Jay Holmgren   +2 more
openalex   +3 more sources

Beyond opioids: The effect of prescription drug monitoring programs on non‐opioid drug prescribing [PDF]

open access: hybridContemporary economic policy
A growing literature has examined how mandatory access prescription drug monitoring programs (MA PDMPs), laws that require providers to consider a patient's prescription history before prescribing controlled substances, affect opioid‐related outcomes ...
David Beheshti, Daewoong Kim
openalex   +2 more sources

The Problem of Data Quality in Analyses of Opioid Regulation: The Case of Prescription Drug Monitoring Programs

open access: gold, 2018
States, which have the primary legal role in regulating the prescribing and dispensing of prescription medications, have created Prescription Drug Monitoring Programs (PDMP) to try to reduce inappropriate prescribing, dispensing, and related harm ...
Jill R. Horwitz   +4 more
openalex   +2 more sources

Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare. [PDF]

open access: greenHealth Serv Res, 2019
Moyo P   +6 more
europepmc   +3 more sources

Helpful, Unnecessary, or Harmful: A Systematic Review of the Effects of Prescription Drug Monitoring Program Use on Opioid Prescriptions

open access: yesPharmacoepidemiology, 2023
Prescription drug misuse is a global problem, especially in the United States (US). Clinician involvement is necessary in this crisis, and prescription drug monitoring programs (PDMPs) are a recommended tool for the prevention, recognition, and ...
Nina Z. Y. Smith   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy